Javascript must be enabled to continue!
Histrelin Implants for Suppression of Puberty in Youth with Gender Dysphoria: A Comparison of 50 mcg/Day (Vantas) and 65 mcg/Day (SupprelinLA)
View through CrossRef
Purpose:
Development of incongruent secondary sex characteristics in transgender youth can intensify or trigger the onset of gender dysphoria. Guidelines from professional organizations recommend gonadotropin-releasing hormone agonists, including histrelin implants (Vantas and SupprelinLA) to suppress endogenous puberty. Although Vantas does not have a pediatric indication, it is anecdotally being used in pediatric gender centers throughout the United States because of its substantially lower cost. This retrospective study aimed to determine if both implants were effective in suppressing the hypothalamic–pituitary–gonadal axis in early-to-mid pubertal youth with gender dysphoria.
Methods:
Youth with gender dysphoria receiving care at the Center for Transyouth Health and Development at Children's Hospital Los Angeles (CHLA) or participants from an ongoing observational trial with a histrelin implant placed for pubertal suppression at Tanner stage 2 or 3 were included. Sex steroid (testosterone or estradiol) and gonadotropin measurements at baseline (T0) and then 2 to 12 months following implant placement (T1) were abstracted from medical records.
Results:
Of the 66 eligible participants, 52% were designated female at birth. Most participants were white (60.6%). Twenty participants (30.3%) had a Vantas implant and 46 (69.7%) had a SupprelinLA implant. Mean age of insertion was 11.3 years. Gonadotropin and sex steroid levels were significantly decreased at T1 (2–12 months after insertion of implant), with no differences between implants.
Conclusion:
These results indicate that both implants are effective in suppressing puberty in early-to-mid pubertal youth with gender dysphoria. These data may inform decisions about insurance coverage of Supprelin and/or Vantas for youth with gender dysphoria.
Title: Histrelin Implants for Suppression of Puberty in Youth with Gender Dysphoria: A Comparison of 50 mcg/Day (Vantas) and 65 mcg/Day (SupprelinLA)
Description:
Purpose:
Development of incongruent secondary sex characteristics in transgender youth can intensify or trigger the onset of gender dysphoria.
Guidelines from professional organizations recommend gonadotropin-releasing hormone agonists, including histrelin implants (Vantas and SupprelinLA) to suppress endogenous puberty.
Although Vantas does not have a pediatric indication, it is anecdotally being used in pediatric gender centers throughout the United States because of its substantially lower cost.
This retrospective study aimed to determine if both implants were effective in suppressing the hypothalamic–pituitary–gonadal axis in early-to-mid pubertal youth with gender dysphoria.
Methods:
Youth with gender dysphoria receiving care at the Center for Transyouth Health and Development at Children's Hospital Los Angeles (CHLA) or participants from an ongoing observational trial with a histrelin implant placed for pubertal suppression at Tanner stage 2 or 3 were included.
Sex steroid (testosterone or estradiol) and gonadotropin measurements at baseline (T0) and then 2 to 12 months following implant placement (T1) were abstracted from medical records.
Results:
Of the 66 eligible participants, 52% were designated female at birth.
Most participants were white (60.
6%).
Twenty participants (30.
3%) had a Vantas implant and 46 (69.
7%) had a SupprelinLA implant.
Mean age of insertion was 11.
3 years.
Gonadotropin and sex steroid levels were significantly decreased at T1 (2–12 months after insertion of implant), with no differences between implants.
Conclusion:
These results indicate that both implants are effective in suppressing puberty in early-to-mid pubertal youth with gender dysphoria.
These data may inform decisions about insurance coverage of Supprelin and/or Vantas for youth with gender dysphoria.
Related Results
The Peripubertal Gender-Dysphoric Child: Puberty Suppression and Treatment Paradigms
The Peripubertal Gender-Dysphoric Child: Puberty Suppression and Treatment Paradigms
Gender-nonconforming youth are emerging at increasingly younger ages, and those experiencing gender dysphoria are seeking medical care at, or sometimes even before, the onset of pu...
Just Kids: Baltimore's Youth in the Adult Criminal Justice System
Just Kids: Baltimore's Youth in the Adult Criminal Justice System
Maryland’s 20 year experiment with the "tough on crime" approach of automatically sending youth into adult criminal courts, jails and prisons for certain offenses has failed. Natio...
(198) THE EFFECT OF PUBERTY SUPPRESSION ON SEXUAL FUNCTIONING IN TRANSWOMEN AFTER GENDER AFFIRMATIVE SURGERY
(198) THE EFFECT OF PUBERTY SUPPRESSION ON SEXUAL FUNCTIONING IN TRANSWOMEN AFTER GENDER AFFIRMATIVE SURGERY
Abstract
Objectives
To improve informed and evidence based care for transgender adolescents by gaining insight into the long-ter...
Hypogonadism in Thalassemia Major.
Hypogonadism in Thalassemia Major.
Abstract
Thalassemia is one of the commonest hereditary hemolytic anemia. 3% to 17% of the population in Indian subcontinent carries beta thalassemia gene. Every yea...
Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn’s Disease
Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn’s Disease
Background & Aims: Loss of response to anti-tumor necrosis factor (TNF) drugs in patients with inflammatory bowel disease is likely due to low drug serum levels, and dosing an...
Abstract 2584: Leukemia latency in the mCG-PML-RARα mouse model is impacted by sex and obesity
Abstract 2584: Leukemia latency in the mCG-PML-RARα mouse model is impacted by sex and obesity
Abstract
Human leukemias have been reported to show sexual dimorphism in both incidence and behavior. However, few studies of this observation have been conducted in...
An Action Plan For Youth Involvement Leadership At Francois In Martinique
An Action Plan For Youth Involvement Leadership At Francois In Martinique
Problem Youth involvement leadership in Seventh-day Adventist local churches remains an issue of concern. Part of the vision of the Seventh-day Adventist World Church and the loca...
A Comparative Study of 25 mcg vs 50 mcg of Vaginal Misoprostol for Induction of Labor
A Comparative Study of 25 mcg vs 50 mcg of Vaginal Misoprostol for Induction of Labor
ABSTRACT
Objectives
To compare the efficacy and safety of 25 mcg intravaginal misoprostol vs 50 mcg misoprostol for induction of labor.
Material and methods
This study group con...

